跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RYBELSUS semaglutide 14 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RYBELSUS semaglutide 14 mg tablet blister pack
Approved
STANDARD
RYBELSUS semaglutide 14 mg tablet blister pack
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a8470d3fccd09669
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
a8470d3fccd09669
Product Name
RYBELSUS semaglutide 14 mg tablet blister pack
Artg Id
346200
Artg Name
RYBELSUS semaglutide 14 mg tablet blister pack
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2022-02-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a8470d3fccd09669
Type
Standard
Back to TGA Approvals
